Back to Authors

Serratosa, José M

0000-0003-2239-8948

Mayo Clinic

Neurology Laboratory and Epilepsy Unit, Department of Neurology, IIS- Fundacio'n Jime'nez Dı'az, UAM, 28040 Madrid, Spain.

Citations 2

4-Aminopyridine is a promising treatment option for patients with gain-of-function KCNA2 -encephalopathy

Science Translational Medicine | September 2, 2021 | Volume: 13 | Issue: 609 | Pages: No page available

10.1126/scitranslmed.aaz4957 | PMID 34516822

4-Aminopyridine is a potential therapeutic option for a subgroup of patients with KCNA2 -encephalopathy and gain-of-function variants.
Clinical spectrum and genotype–phenotype associations of KCNA2-related encephalopathies

Brain | June 29, 2017 | Volume: 140 | Issue: 9 | Pages: 2337-2354

10.1093/brain/awx184 | PMID 29050392